NASHUA, N.H., Nov. 06, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. ICAD, a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter and nine months ended September 30, 2018 after the close of the market and host a conference call at 4:30pm Eastern Time on Tuesday, November 13th.
| Tuesday, November 13th @ 4:30pm Eastern Time | |
| Domestic: | 888-599-8686 |
| International: | 323-994-2093 |
| Conference ID: | 1529049 |
| Webcast: | http://public.viavid.com/index.php?id=131972 |
| Replays available through November 27th: | |
| Domestic: | 844-512-2921 |
| International: | 412-317-6671 |
| Replay PIN: | 1529049 |
In addition, a replay of the call will remain on the Company's website (www.icadmed.com) until the Company releases its fourth quarter and year ended 2018 financial results.
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
ARPR, on behalf of iCAD, Inc.
Paul Barren
(855) 300-8209
paul@arpr.com
or
Investor Relations:
LifeSci Advisors
Jeremy Feffer
(212) 915-2568
jeremy@lifesciadvisors.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
